Forms of Circulating Luteinizing Hormone Human Chorionic Gonadotropin Receptor for the Prediction of Early and Late Preeclampsia in the First Trimester of Pregnancy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Fetal Diagnosis and Therapy

• Publication date

  2015-02-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000371516PMID 25676660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy

  2014cited by this paper
• Added Value of Angiogenic Factors for the Prediction of Early and Late Preeclampsia in the First Trimester of Pregnancy

  2014cited by this paper
• First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia

  2013cited by this paper
• First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

  2013cited by this paper
• Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre‐eclampsia in a low‐risk nulliparous patient population?

  2013cited by this paper
• Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting.

  2013cited by this paper
• Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy

  2013cited by this paper
• First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk

  2012cited by this paper
• Candidate biochemical markers for screening of pre-eclampsia in early pregnancy

  2012cited by this paper
• Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

  2012cited by this paper
• Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Early Administration of Low-Dose Aspirin for the Prevention of Severe and Mild Preeclampsia: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.

  2012cited by this paper
• Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down’s syndrome, preterm delivery and preeclampsia

  2012cited by this paper
• Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks

  2011cited by this paper
• Uterine artery Doppler and biochemical markers (PAPP‐A, PlGF, sFlt‐1, P‐selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (>34 weeks) pre‐eclampsia

  2011cited by this paper
• Hypertensive Disorders in Pregnancy: Screening by Systolic Diastolic and Mean Arterial Pressure at 11–13 Weeks

  2011cited by this paper
• Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia – a case–control study

  2011cited by this paper
• Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis

  2010cited by this paper
• Maternal plasma soluble fms‐like tyrosine kinase‐1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia

  2010cited by this paper
• The global impact of pre-eclampsia and eclampsia.

  2009cited by this paper
• Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks

  2009cited by this paper
• Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre‐eclampsia

  2008cited by this paper
• The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

  2008cited by this paper
• Customized birthweight standards for a Spanish population.

  2008cited by this paper
• Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia

  2008cited by this paper
• First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

  2008cited by this paper
• Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.

  2007cited by this paper
• Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

  2006cited by this paper
• A permutation test for inference in logistic regression with small‐ and moderate‐sized data sets by D. M. Potter, Statistics in Medicine 2005; 24:693–708

  2006cited by this paper
• Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome

  2006cited by this paper
• World Health Organization systematic review of screening tests for preeclampsia.

  2005cited by this paper
• Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population

  2005cited by this paper
• A permutation test for inference in logistic regression with small‐ and moderate‐sized data sets

  2005cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• World Health Organization Systematic Review of Screening Tests for Preeclampsia

  2004cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

  2004cited by this paper
• The cerebroplacental Doppler ratio revisited

  2003cited by this paper
• The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

  2001cited by this paper
• On the Role of Human Chorionic Gonadotropin (hCG) in the Embryo-Endometrial Microenvironment: Implications for Differentiation and Implantation

  2001cited by this paper
• First‐trimester biochemical markers for Down syndrome

  1999cited by this paper
• A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS

  1975cited by this paper
• Bmc Medical Research Methodology Open Access Advantages of the Nested Case-control Design in Diagnostic Research

  year unknowncited by this paper

• Soluble luteinizing hormone receptor in follicular fluid and the association with reproductive function during IVF and ICSI.

  2024cites this paper
• First trimester serum matrix metalloproteinase-7 is a poor predictor of late-onset preeclampsia.

  2022cites this paper
• First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study

  2022cites this paper
• Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis

  2021cites this paper
• Soluble LH-HCG receptor and oestradiol as predictors of pregnancy and live birth in IVF.

  2019cites this paper
• Personalizing obstetric care: prediction and prevention of adverse pregnancy outcomes

  2018cites this paper
• Premature and multiple births in IVF are associated with pretreatment circulating LH/hCG receptor concentration

  2017cites this paper
• Prenatal Diagnosis and Treatment of Spina Bifida

  2015cites this paper